Walgreens Boots Alliance, Inc. (0LSZ.L)
USD 10.0
(2.35%)
USD 10.0
(2.35%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 147.65 Billion USD | 6.17% |
| 2023 | 139.08 Billion USD | 4.81% |
| 2022 | 132.7 Billion USD | 0.15% |
| 2021 | 132.5 Billion USD | 8.63% |
| 2020 | 121.98 Billion USD | 1.59% |
| 2019 | 120.07 Billion USD | -8.71% |
| 2018 | 131.53 Billion USD | 11.27% |
| 2017 | 118.21 Billion USD | 0.74% |
| 2016 | 117.35 Billion USD | 13.44% |
| 2015 | 103.44 Billion USD | 35.41% |
| 2014 | 76.39 Billion USD | 5.78% |
| 2013 | 72.21 Billion USD | 0.82% |
| 2012 | 71.63 Billion USD | -0.76% |
| 2011 | 72.18 Billion USD | 7.07% |
| 2010 | 67.42 Billion USD | 6.45% |
| 2009 | 63.33 Billion USD | 7.29% |
| 2008 | 59.03 Billion USD | 9.81% |
| 2007 | 53.76 Billion USD | 13.4% |
| 2006 | 47.4 Billion USD | 12.34% |
| 2005 | 42.2 Billion USD | 12.51% |
| 2004 | 37.5 Billion USD | 15.39% |
| 2003 | 32.5 Billion USD | 13.33% |
| 2002 | 28.68 Billion USD | 16.48% |
| 2001 | 24.62 Billion USD | 16.11% |
| 2000 | 21.2 Billion USD | 18.88% |
| 1999 | 17.83 Billion USD | 16.54% |
| 1998 | 15.3 Billion USD | 14.55% |
| 1997 | 13.36 Billion USD | 13.45% |
| 1996 | 11.77 Billion USD | 13.31% |
| 1995 | 10.39 Billion USD | 12.56% |
| 1994 | 9.23 Billion USD | 11.33% |
| 1993 | 8.29 Billion USD | 10.97% |
| 1992 | 7.47 Billion USD | 11.02% |
| 1991 | 6.73 Billion USD | 11.34% |
| 1990 | 6.04 Billion USD | 12.4% |
| 1989 | 5.38 Billion USD | 10.17% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 37.05 Billion USD | 0.94% |
| 2024 Q1 | 36.7 Billion USD | 3.63% |
| 2024 Q3 | 36.35 Billion USD | -1.89% |
| 2024 Q4 | 37.54 Billion USD | 3.29% |
| 2023 Q2 | 34.86 Billion USD | 4.43% |
| 2023 Q4 | 35.42 Billion USD | 0.02% |
| 2023 Q1 | 33.38 Billion USD | 2.88% |
| 2023 FY | 139.08 Billion USD | 4.81% |
| 2023 Q3 | 35.41 Billion USD | 1.59% |
| 2022 Q4 | 32.44 Billion USD | -0.45% |
| 2022 Q1 | 33.9 Billion USD | -1.05% |
| 2022 FY | 132.7 Billion USD | 0.15% |
| 2022 Q3 | 32.59 Billion USD | -3.43% |
| 2022 Q2 | 33.75 Billion USD | -0.43% |
| 2021 FY | 132.5 Billion USD | -5.04% |
| 2021 Q1 | 31.43 Billion USD | 3.52% |
| 2021 Q2 | 32.77 Billion USD | 4.27% |
| 2021 Q3 | 34.03 Billion USD | 3.82% |
| 2021 Q4 | 34.26 Billion USD | 0.68% |
| 2020 Q4 | 30.37 Billion USD | 0.02% |
| 2020 FY | 139.53 Billion USD | 1.95% |
| 2020 Q1 | 29.91 Billion USD | -11.91% |
| 2020 Q2 | 31.33 Billion USD | 4.76% |
| 2020 Q3 | 30.36 Billion USD | -3.1% |
| 2019 Q3 | 34.59 Billion USD | 0.18% |
| 2019 FY | 136.86 Billion USD | 4.05% |
| 2019 Q2 | 34.52 Billion USD | 2.18% |
| 2019 Q1 | 33.79 Billion USD | 1.05% |
| 2019 Q4 | 33.95 Billion USD | -1.84% |
| 2018 Q2 | 33.02 Billion USD | 7.42% |
| 2018 FY | 131.53 Billion USD | 11.27% |
| 2018 Q1 | 30.74 Billion USD | 1.96% |
| 2018 Q3 | 34.33 Billion USD | 3.98% |
| 2018 Q4 | 33.44 Billion USD | -2.6% |
| 2017 Q4 | 30.14 Billion USD | 0.1% |
| 2017 Q2 | 29.44 Billion USD | 3.32% |
| 2017 Q1 | 28.5 Billion USD | -0.47% |
| 2017 Q3 | 30.11 Billion USD | 2.28% |
| 2017 FY | 118.21 Billion USD | 0.74% |
| 2016 Q1 | 29.03 Billion USD | 1.79% |
| 2016 Q2 | 30.18 Billion USD | 3.96% |
| 2016 Q4 | 28.63 Billion USD | -2.92% |
| 2016 FY | 117.35 Billion USD | 13.44% |
| 2016 Q3 | 29.49 Billion USD | -2.27% |
| 2015 FY | 103.44 Billion USD | 35.41% |
| 2015 Q4 | 28.52 Billion USD | -0.95% |
| 2015 Q3 | 28.79 Billion USD | 8.36% |
| 2015 Q2 | 26.57 Billion USD | 35.9% |
| 2015 Q1 | 19.55 Billion USD | 2.61% |
| 2014 FY | 76.39 Billion USD | 5.78% |
| 2014 Q1 | 18.32 Billion USD | 2.16% |
| 2014 Q2 | 19.6 Billion USD | 6.96% |
| 2014 Q4 | 19.05 Billion USD | -1.77% |
| 2014 Q3 | 19.4 Billion USD | -1.04% |
| 2013 FY | 72.21 Billion USD | 0.82% |
| 2013 Q3 | 18.31 Billion USD | -1.79% |
| 2013 Q1 | 17.31 Billion USD | 1.42% |
| 2013 Q2 | 18.64 Billion USD | 7.69% |
| 2013 Q4 | 17.94 Billion USD | -2.03% |
| 2012 Q4 | 17.07 Billion USD | -3.82% |
| 2012 Q1 | 18.15 Billion USD | 1.06% |
| 2012 Q3 | 17.75 Billion USD | -4.82% |
| 2012 Q2 | 18.65 Billion USD | 2.72% |
| 2012 FY | 71.63 Billion USD | -0.76% |
| 2011 Q2 | 18.5 Billion USD | 6.68% |
| 2011 FY | 72.18 Billion USD | 7.07% |
| 2011 Q4 | 17.96 Billion USD | -2.2% |
| 2011 Q3 | 18.37 Billion USD | -0.71% |
| 2011 Q1 | 17.34 Billion USD | 2.81% |
| 2010 Q4 | 16.87 Billion USD | -1.91% |
| 2010 FY | 67.42 Billion USD | 6.45% |
| 2010 Q3 | 17.19 Billion USD | 1.25% |
| 2010 Q2 | 16.98 Billion USD | 3.81% |
| 2010 Q1 | 16.36 Billion USD | 4.21% |
| 2009 Q2 | 16.47 Billion USD | 10.22% |
| 2009 Q3 | 16.21 Billion USD | -1.61% |
| 2009 Q4 | 15.7 Billion USD | -3.13% |
| 2009 FY | 63.33 Billion USD | 7.29% |
| 2009 Q1 | 14.94 Billion USD | 2.4% |
| 2008 Q1 | 14.02 Billion USD | 4.52% |
| 2008 FY | 59.03 Billion USD | 9.81% |
| 2008 Q3 | 15.01 Billion USD | -2.45% |
| 2008 Q4 | 14.59 Billion USD | -2.79% |
| 2008 Q2 | 15.39 Billion USD | 9.74% |
| 2007 Q4 | 13.42 Billion USD | -2.02% |
| 2007 Q2 | 13.93 Billion USD | 9.64% |
| 2007 FY | 53.76 Billion USD | 13.4% |
| 2007 Q3 | 13.69 Billion USD | -1.69% |
| 2007 Q1 | 12.7 Billion USD | 4.42% |
| 2006 Q3 | 12.17 Billion USD | 0.1% |
| 2006 FY | 47.4 Billion USD | 12.34% |
| 2006 Q1 | 10.9 Billion USD | 3.86% |
| 2006 Q2 | 12.16 Billion USD | 11.58% |
| 2006 Q4 | 12.17 Billion USD | -0.04% |
| 2005 Q2 | 10.98 Billion USD | 11.1% |
| 2005 Q1 | 9.88 Billion USD | 4.91% |
| 2005 Q3 | 10.83 Billion USD | -1.42% |
| 2005 Q4 | 10.49 Billion USD | -3.1% |
| 2005 FY | 42.2 Billion USD | 12.51% |
| 2004 FY | 37.5 Billion USD | 15.39% |
| 2004 Q2 | 9.78 Billion USD | 12.17% |
| 2004 Q3 | 9.57 Billion USD | -2.08% |
| 2004 Q4 | 9.42 Billion USD | -1.58% |
| 2004 Q1 | 8.72 Billion USD | 5.75% |
| 2003 Q1 | 7.48 Billion USD | 3.45% |
| 2003 Q4 | 8.24 Billion USD | -0.98% |
| 2003 Q3 | 8.32 Billion USD | -1.4% |
| 2003 Q2 | 8.44 Billion USD | 12.84% |
| 2003 FY | 32.5 Billion USD | 13.33% |
| 2002 Q3 | 7.39 Billion USD | -1.21% |
| 2002 Q4 | 7.23 Billion USD | -2.2% |
| 2002 Q2 | 7.48 Billion USD | 14.16% |
| 2002 Q1 | 6.55 Billion USD | 4.39% |
| 2002 FY | 28.68 Billion USD | 16.48% |
| 2001 Q4 | 6.28 Billion USD | -0.2% |
| 2001 FY | 24.62 Billion USD | 16.11% |
| 2001 Q3 | 6.29 Billion USD | -2.07% |
| 2001 Q2 | 6.42 Billion USD | 14.51% |
| 2001 Q1 | 5.61 Billion USD | 4.34% |
| 2000 Q4 | 5.38 Billion USD | -0.25% |
| 2000 Q2 | 5.6 Billion USD | 16.29% |
| 2000 Q3 | 5.39 Billion USD | -3.83% |
| 2000 Q1 | 4.82 Billion USD | 5.77% |
| 2000 FY | 21.2 Billion USD | 18.88% |
| 1999 Q4 | 4.56 Billion USD | -0.25% |
| 1999 Q1 | 4.01 Billion USD | 4.56% |
| 1999 FY | 17.83 Billion USD | 16.54% |
| 1999 Q2 | 4.69 Billion USD | 16.81% |
| 1999 Q3 | 4.57 Billion USD | -2.55% |
| 1998 Q4 | 3.84 Billion USD | -1.18% |
| 1998 Q2 | 4.09 Billion USD | 17.47% |
| 1998 Q3 | 3.88 Billion USD | -5.06% |
| 1998 Q1 | 3.48 Billion USD | 5.51% |
| 1998 FY | 15.3 Billion USD | 14.55% |
| 1997 Q2 | 3.6 Billion USD | 17.96% |
| 1997 Q4 | 3.3 Billion USD | -2.94% |
| 1997 FY | 13.36 Billion USD | 13.45% |
| 1997 Q1 | 3.05 Billion USD | 4.67% |
| 1997 Q3 | 3.4 Billion USD | -5.53% |
| 1996 Q3 | 2.98 Billion USD | -5.99% |
| 1996 FY | 11.77 Billion USD | 13.31% |
| 1996 Q1 | 2.69 Billion USD | 4.97% |
| 1996 Q2 | 3.17 Billion USD | 18.06% |
| 1996 Q4 | 2.91 Billion USD | -2.38% |
| 1995 Q1 | 2.4 Billion USD | 5.39% |
| 1995 Q4 | 2.56 Billion USD | -1.99% |
| 1995 Q3 | 2.61 Billion USD | -6.75% |
| 1995 Q2 | 2.8 Billion USD | 16.69% |
| 1995 FY | 10.39 Billion USD | 12.56% |
| 1994 FY | 9.23 Billion USD | 11.33% |
| 1994 Q1 | 2.11 Billion USD | 3.98% |
| 1994 Q4 | 2.28 Billion USD | -2.29% |
| 1994 Q3 | 2.33 Billion USD | -6.5% |
| 1994 Q2 | 2.49 Billion USD | 17.97% |
| 1993 Q3 | 2.08 Billion USD | -7.64% |
| 1993 Q4 | 2.03 Billion USD | -2.32% |
| 1993 Q2 | 2.25 Billion USD | 17.93% |
| 1993 Q1 | 1.91 Billion USD | 3.92% |
| 1993 FY | 8.29 Billion USD | 10.97% |
| 1992 Q1 | 1.7 Billion USD | 2.48% |
| 1992 Q4 | 1.84 Billion USD | -2.32% |
| 1992 FY | 7.47 Billion USD | 11.02% |
| 1992 Q2 | 2.03 Billion USD | 19.27% |
| 1992 Q3 | 1.88 Billion USD | -7.46% |
| 1991 Q4 | 1.66 Billion USD | -2.18% |
| 1991 Q1 | 1.54 Billion USD | 3.23% |
| 1991 Q2 | 1.82 Billion USD | 18.2% |
| 1991 FY | 6.73 Billion USD | 11.34% |
| 1991 Q3 | 1.7 Billion USD | -6.39% |
| 1990 Q3 | 1.52 Billion USD | -7.58% |
| 1990 Q1 | 1.38 Billion USD | 3.42% |
| 1990 FY | 6.04 Billion USD | 12.4% |
| 1990 Q2 | 1.64 Billion USD | 18.73% |
| 1990 Q4 | 1.49 Billion USD | -1.94% |
| 1989 FY | 5.38 Billion USD | 10.17% |
| 1989 Q4 | 1.34 Billion USD | -0.72% |
| 1989 Q3 | 1.35 Billion USD | -8.53% |
| 1989 Q1 | 1.21 Billion USD | 0.82% |
| 1989 Q2 | 1.47 Billion USD | 21.87% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Editas Medicine, Inc. | 78.12 Million USD | -188907.079% |
| Dynavax Technologies Corporation | 232.28 Million USD | -63467.874% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | -24205.003% |
| Perrigo Company plc | 4.65 Billion USD | -3071.621% |
| Illumina, Inc. | 4.5 Billion USD | -3178.375% |
| Thermo Fisher Scientific Inc. | 42.85 Billion USD | -244.536% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -12418571.152% |
| IQVIA Holdings Inc. | 14.98 Billion USD | -885.438% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -116125.875% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | -1025.682% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Waters Corporation | 2.95 Billion USD | -4894.493% |
| Biogen Inc. | 9.83 Billion USD | -1401.261% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -83686.146% |
| Evolus, Inc. | 202.08 Million USD | -72967.274% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -704106.41% |
| bluebird bio, Inc. | 29.49 Million USD | -500486.5% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | -126825.92% |
| FibroGen, Inc. | 147.75 Million USD | -99836.38% |
| Agilent Technologies, Inc. | 6.83 Billion USD | -2060.954% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Homology Medicines, Inc. | -6.65 Million USD | 2220187.205% |
| Geron Corporation | 237 Thousand USD | -62302853.586% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -7976.281% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -36874.028% |
| Myriad Genetics, Inc. | 678.4 Million USD | -21665.625% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -406951.688% |
| Zoetis Inc. | 8.54 Billion USD | -1628.207% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -4218700.0% |
| Mettler-Toledo International Inc. | 3.78 Billion USD | -3797.729% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | -6003.522% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | -1396.15% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -18646.723% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -1722260.901% |
| Verastem, Inc. | - USD | -Infinity% |
| Nektar Therapeutics | 90.12 Million USD | -163742.347% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -54466.888% |
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -472420.721% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -11775.953% |
| OPKO Health, Inc. | 863.49 Million USD | -17000.041% |
| Exelixis, Inc. | 1.83 Billion USD | -7967.826% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | -7724.599% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -30510.625% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -931907.827% |
| Imunon, Inc. | - USD | -Infinity% |
| Blueprint Medicines Corporation | 249.38 Million USD | -59110.041% |
| Insmed Incorporated | 305.2 Million USD | -48279.466% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -17706.146% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -550390.251% |
| TG Therapeutics, Inc. | 233.66 Million USD | -63092.988% |
| Incyte Corporation | 3.69 Billion USD | -3895.455% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -13972.048% |